A Study of the Comparable Efficacy and Safety of Pulmozyme (Dornase Alfa) Delivered by the eRapid Nebulizer System in Patients With Cystic Fibrosis
Clinical trial NCT01712334 · COMPLETED
Trial details
- NCT number
- NCT01712334
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-01
- Primary completion
- 2013-06-01
- Enrollment
- 99
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.